针对细菌感染的mRNA疫苗开发的当前进展
Alina Khlebnikova1, Anna Kirshina1, Natalia Zakharova1
1Translational Medicine Research Center, Sirius University of Science and Technology, Sochi 354340, Russia.
International journal of molecular sciences
|December 17, 2024
概括
使者RNA (mRNA) 疫苗在预防细菌感染方面表现有前途,为对抗不断演变的病原体提供了一种新策略. 本综述探讨了动物模型中细菌mRNA疫苗的当前研究和潜在改进.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 由于抗生素耐药性和细菌进化,细菌感染构成了持续的威胁.
- 传统的抗生素越来越无效,需要新的方法来控制细菌感染.
- 传递者RNA (mRNA) 疫苗技术在病毒性疾病中取得了成功,目前正在探索细菌感染.
研究的目的:
- 审查针对细菌病原体的mRNA疫苗的开发和临床前测试.
- 分析与疫苗设计相关的细菌免疫逃避机制.
- 讨论提高细菌mRNA疫苗疗效的策略.
主要方法:
- 对针对细菌感染的mRNA疫苗开发现有文献的综述.
- 细菌结构特征和免疫逃避策略的分析.
- 从使用细菌mRNA疫苗的动物模型中检查体内实验结果.
主要成果:
- 已经开发了mRNA疫苗,并在动物模型中对9种细菌物种进行了测试.
- 细菌与宿主免疫相互作用的复杂性对疫苗有效性提出了挑战.
- 临床前数据表明了潜在的可能性,但也突出了细菌mRNA疫苗设计的改进领域.
结论:
- mRNA疫苗代表了对抗细菌感染的有希望的途径.
- 需要进一步的研究来克服与细菌复杂性和免疫逃避有关的挑战.
- 优化细菌mRNA疫苗战略对于未来的临床应用至关重要.
关键词:
B. burgdorferiferi. 这里是我们的地方.L.单细胞原体.在M.结核病.在P. aeruginosa的研究中,P.这是一种RNA疫苗.在S. pyogenes的基础上.细菌感染 细菌感染更多相关视频
10:16Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
3.2K
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
1.8K
相关概念视频
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Initiation of Translation
30.7K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
30.7K
Types of RNA
63.2K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.2K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Improving Translational Accuracy
8.8K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
8.8K
